Form 10-K Immunovant, Inc. For: Mar 31
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St subdued as markets pause after S&P record high; data, Mideast in focus
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Raymond James Downgrades Immunovant (IMVT) to Market Perform
June 1, 2021 3:31 PM EDTRaymond James analyst Danielle Brill downgraded Immunovant (NASDAQ: IMVT) from Outperform to Market Perform.
For an analyst ratings summary and ratings history on Immunovant click here. For more ratings news on Immunovant click here.
Shares of Immunovant closed at $15.16 yesterday.
... MoreGuggenheim Downgrades Immunovant (IMVT) to Neutral
June 1, 2021 1:22 PM EDTGuggenheim analyst Yatin Suneja downgraded Immunovant (NASDAQ: IMVT) from Buy to Neutral.
For an analyst ratings summary and ratings history on Immunovant click here. For more ratings news on Immunovant click here.
Shares of Immunovant closed at $15.16 yesterday.
... MoreImmunovant (IMVT) PT Lowered to $24 at Truist Securities
June 1, 2021 11:45 AM EDTTruist Securities analyst Robyn Karnauskas lowered the price target on Immunovant (NASDAQ: IMVT) to $24.00 (from $48.00) while maintaining a Buy rating on the disappointing TED news.
The analyst commented, "TED data likely a disappointment, given prior due-diligence indicating a potential oppy in... More
